Showing 1 - 20 results of 57 for search '"постменопаузальный период"', query time: 0.96s Refine Results
  1. 1
    Academic Journal

    Source: Bolʹ, Sustavy, Pozvonočnik, Vol 8, Iss 3, Pp 134-139 (2018)
    PAIN. JOINTS. SPINE; Том 8, № 3 (2018); 134-139
    Боль. Суставы. Позвоночник-Bolʹ, sustavy, pozvonočnik; Том 8, № 3 (2018); 134-139
    Біль. Суглоби. Хребет-Bolʹ, sustavy, pozvonočnik; Том 8, № 3 (2018); 134-139

    File Description: application/pdf

  2. 2
  3. 3
    Academic Journal

    Contributors: The study was performed with the support of the National Medical Research Center for Therapy and Preventive Medicine., Исследование проведено при поддержке Национального медицинского исследовательского центра терапии и профилактической медицины.

    Source: Rational Pharmacotherapy in Cardiology; Vol 19, No 1 (2023); 11-16 ; Рациональная Фармакотерапия в Кардиологии; Vol 19, No 1 (2023); 11-16 ; 2225-3653 ; 1819-6446

    File Description: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/2881/2394; Rossi LMM, Copes RM, Dal Osto LC, et al. Factors related with osteoporosis treatment in postmenopausal women. Medicine (Baltimore). 2018;97(28):11524. DOI:10.1097/MD.0000000000011524.; Anagnostis P, Karagiannis A, Kakafika AI, et al. Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int. 2009;20(2):197-207. DOI:10.1007/s00198-008-0648-5.; Sinnott B, Syed I, Sevrukov A, Barengolts E. Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int. 2006;78(4):195202. DOI:10.1007/s00223-005-0244-z.; Ye C. Decreased bone mineral density is an independent predictor for the development of atherosclerosis: a systematic review and meta-analysis. PLoS One. 2016;11(5):e0154740. DOI:10.1371/journal.pone.0154740.; Wang X, Le EPV, Rajani NK, et al. A zero coronary artery calcium score in patients with stable chest pain is associated with a good prognosis, despite risk of non-calcified plaques. Open Heart. 2019;6(1):e000945. DOI:10.1136/openhrt-2018-000945.; García-Gómez M, Vilahur G. Osteoporosis and vascular calcification: a shared scenario. Clin Investig Arterioscler. 2020;32(1):33-42. DOI:10.1016/j.arteri.2019.03.008.; Townsend RR, Wilkinson IB, Schiffrin EL, et al. American Heart Association Council on Hypertension. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness. A Scientific Statement from the American Heart Association. J Hypertension. 2015;66(3):698-722. DOI:10.1161/HYP.0000000000000033.; Ferrari R, Aguiar C, Alegria E, et al.Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia, Eur Heart J Suppl. 2016;18(Suppl C):2-12. DOI:10.1093/eurheartj/suw009.; Заирова А.Р., Рогоза А.Н., Каминная В.И., и др. Артериальная жесткость у больных с атеросклерозом и дислипидемией на фоне медикаментозной терапии как возможный маркер резидуального риска. Атеросклероз и Дислипидемии. 2022;(3):29-40. DOI:10.34687/2219-8202.JAD.2022.03.0004.; Gustavsson A, Stomrud E, Abul-Kasim K, et al. Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness. Cerebrovasc Dis Extra. 2015;20;5(2):41-51. DOI:10.1159/000377710.; Васюк Ю.А., Иванова С.В., Школьник Е.Л., и др. Согласованное мнение российских экспертов по оценке артериальной жесткости в клинической практике. Кардиоваскулярная Терапия и Профилактика. 2016;15(2);4-19. DOI:10.15829/1728-8800-2016-2-4-19.; Mikumo M, Okano H, Yoshikata R, et al. Association between lumbar bone mineral density and vascular stiffness as assessed by pulse wave velocity in postmenopausal women. J Bone Miner Metab. 2009;27(1):89‐94. DOI:10.1007/s00774-008-0014-x.; Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445-8. DOI:10.1097/HJH.0b013e32834fa8b0.; Лесняк О.М., ред. Остеопороз: диагностика, профилактика и лечение. Руководство для врачей. М.: ГЭОТАР-Медиа; 2016.; Lampropolos CE, Papaioannou I, D’Cruz DP. Osteoporosis-a risk factor for cardiovascular disease? Nat Rev Rheumatol. 2012;8(10):587-98. DOI:10.1038/nrrheum.2012.120.; Алиева А.С., Бояринова М.А., Орлов А.В., и др. Сравнительный анализ методов диагностики субклинического поражения сосудов (на примере выборки эпидемиологического исследования ЭССЕ-РФ). Российский Кардиологический Журнал. 2016;21(6):20-6. DOI:10.15829/1560-4071-2016-6-20-26.; Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021-104. DOI:10.1093/eurheartj/ehy339.; Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588-605. DOI:10.1093/eurheartj/ehl254.; Ерина А.М., Бояринова М.А., Могучая Е.В., и др. Маркеры поражения сосудов в зависимости от уровня артериального давления в популяционной выборке (по материалам ЭССЕ-РФ). Российский Кардиологический Журнал. 2020;25(6):3652. DOI:10.15829/1560-4071-2020-3652.; Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension. a systematic review. Hypertension. 2009;54(6):1328-36. DOI:10.1161/HYPERTENSIONAHA.109.137653.; Seo SK. Decreased bone mineral density is associated with coronary atherosclerosis in healthy postmenopausal women. Obstet Gynecol Sci. 2015;1(2):144-9. DOI:10.5468/ogs.2015.58.2.144.; Jaalkhorol M, Fujita Y, Kouda K, et al. Low bone mineral density is associated with an elevated risk of developing increased arterial stiffness: A 10-year follow-up of Japanese women from the Japanese Population-based Osteoporosis (JPOS) cohort study. Maturitas. 2019;119:39-45. DOI:10.1016/j.maturitas.2018.11.001.; Tap L, Kirkham FA, Mattace-Raso F, et al. Unraveling the Links Underlying Arterial Stiffness, Bone Demineralization, and Muscle Loss. Hypertension. 2020;76(3):629-39. DOI:10.1161/HYPERTENSIONAHA.120.15184.; Агеев Ф.Т., Баринова И.В., Середенина Е.М., и др. Остеопороз и жесткость артерий: исследование 103 женщин с умеренным и низким риском развития сердечно-сосудистых заболеваний. Кардиология. 2013;6:51-8.; Алиханова Н.А., Скрипникова И.А., Ткачева О.Н., и др. Ассоциация параметров сосудистой жесткости и субклинического атеросклероза с костной массой у женщин в постменопаузе. Кардиоваскулярная Терапия и Профилактика. 2016;15(2):51-6. DOI:10.15829/1728-8800-2016-2-51-56.; https://www.rpcardio.com/jour/article/view/2881

  4. 4
    Academic Journal

    Source: Actual Problems of Pediatrics, Obstetrics and Gynecology; No. 2 (2019); 25-31 ; Актуальные вопросы педиатрии, акушерства и гинекологии; № 2 (2019); 25-31 ; Актуальні питання педіатрії, акушерства та гінекології; № 2 (2019); 25-31 ; 2415-301X ; 2411-4944 ; 10.11603/24116-4944.2019.2

    File Description: application/pdf

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
    Academic Journal
  10. 10
  11. 11
  12. 12
    Academic Journal

    Source: Scientific digest of association of obstetricians and gynecologists of Ukraine; № 2(44) (2019); 66-71
    СБОРНИК НАУЧНЫХ ТРУДОВ Ассоциации акушеров-гинекологов Украины; № 2(44) (2019); 66-71
    Збірник наукових праць Асоціації акушерів-гінекологів України; № 2(44) (2019); 66-71

    File Description: application/pdf

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
    Academic Journal

    Source: Malignant tumours; Том 2, № 2 (2012); 6-11 ; Злокачественные опухоли; Том 2, № 2 (2012); 6-11 ; 2587-6813 ; 2224-5057

    File Description: application/pdf

    Relation: https://www.malignanttumors.org/jour/article/view/21/25; Семиглазов В.Ф., Манихас А.Г., Семиглазова Т.Ю., Бессонов А.А., Семиглазов В.В. Неоадъювантная системная терапия рака молочной железы. (Руководство). Аграф., 2012.-112 с.; Семиглазов В.Ф., Семиглазов B.B., Дашян Г.А. Эндокринотерапия раннего рака молочной железы. Руководство. М., «МЕДпресс-информ»,- 2011 -96 с.; Aebi S, Sun Z, Braun D et al.’Differential efficacy of three cycles of CMF followed by tamoxifen in patients with HR-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX. Ann Oncol 2011; - Vol. - 22, pp. 179-189.; Albain KS, Barlow WE, Ravdin PM et al. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node- positive breast cancer: a phase 3, open-label, randomized controlled trial. Lancet 2009; - Vol. - 374: pp 2055-2063.; Baselga J., Semiglazov V., van Dam P. et.al. Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor - positive breast cancer // J.Clin Oncol - 2009. -Vol.-27(6).-p. 2630-2637Ю; Colleoni M, Adjuvant therapies for special types of breast cancer (abstr. S240)// The Breast. – 2011. – Vol. 20 (suppl.1). – P.15; Gianni L, Eiermann W, Semiglazov V et al. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2 – positive locally advanced breast cancer (the NOAH trial): a randomized controlled superiority trial with a parallel HER2 – negative cohort // Lancet. – 2010. – Vol.375.- P.377-384.; Cheang MCU, Chia SK, Voduc D et al. Ki67 index, HER2 status, and prognosis of patients with luminal В breast cancer. J Natl Cancer Inst 2009; Vol.-101: pp. 736-750.; Goldhirsch A, Ingle JN, Gelber RD et al. Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the-Primary Therapy of Early Breast Cancer 2009. Ann Oncol 2009; - Vol. - 20: pp. 1319-1329.; Johnston J. How to treat ER – positive HER2 – positive breast cancer. J Clin Oncol., 2009 – vol.27.- p.5529-5538.; Liedtke C, Mazouni C, Hess KR et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008; - Vol. - 26: pp. 1275-1281.; Millikan RC, Newman B, Tse CK et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008; - Vol. - 109: pp. 123-139.; Nguyen PL, Taghian AG, Katz MS et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008; - Vol. - 26: pp.2373-2378.; Parker JS, Mullins M, Cheang MCU et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; - Vol. - 27: pp.1160- 1167.; Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; - Vol. - 406: pp. 747-752.; Phipps Al, Buist DS, Malone KE et al. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2011; - Vol. - 22: pp.399-405.; Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol 2011 - Vol. -;5: pp. 5-23.; Semiglazov V.F., Semiglazov V.V., Ivanov V. et al. The relative efficacy of neoadjuvant endocrine therapy vs postmenopausal women with ER-positive breast cancer // J. Clin. Oncol. - 2004. - vol. 22. - p. 519.; Semiglazov V.F., Semigiazov V.V., Dashyan G. et al. Randomized trial of primary endocrine therapy chemotherapy in postmenopausal patients with estrogen receptor positive breast cancer // Cancer. - 2007. - vol. 110 - p. 244 -254.; Tang G, Shak S, Paik S et al. Comparison of the prognostic and predictive utilities of the 21- gene recurrence score assay and Adjuvant! for women with nodenegative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20. Breast Cancer Res Treat 2011; - Vol. - 320: pp. 1112-1120.; Wo JY, Taghian AG, Nguyen PL et al. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy. Int J Radiat Oncol Biol Phys 2010; - Vol. - 77: pp. 188-196.; https://www.malignanttumors.org/jour/article/view/21

  18. 18
  19. 19
  20. 20